Cardiovascular Disease

Relevant Pages

HIV - Epidemiology of HIV Infection in the Developed World

• Mortality in HIV-Infected Populations
• Cardiovascular and Metabolic Disorders

HIV - Management of Renal Disease

• General Treatment for Kidney Disease
• Introduction
• Microalbuminuria and Cardiovascular Risk

HIV - The Approach to the HIV-Infected Patient With Specific Symptom Complexes/Common Presentations

• Diseases Common to the General Population
• Cardiac Manifestations: Etiology and Diagnostic Approach

HIV - Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

• Recommendations for Special Situations
• Safety Considerations With Tenofovir DF and Abacavir

HIV - Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients

• Modifying Boosted PI Regimens in Virologically Suppressed Patients

HIV - Timing of Initiation of First-line Antiretroviral Therapy

• Specific Patients

HIV - Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

• Introduction
• Screening, Treatment, and Monitoring for Dyslipidemia in HIV-Infected Patients
• Cardiovascular Disease in HIV-Infected Patients
• Primary Care Essentials

HIV - Agents Used in Antiretroviral Therapy

• PIs in Common Usage
• NRTIs in Common Usage
• Lopinavir/Ritonavir
• Indinavir
• Ritonavir

HIV - Special Considerations in the Management of HIV-Infected Patients From Minority Communities

• Cardiovascular Disease
• Metabolic Syndrome and Diabetes

HIV - Special Considerations Related to Aging in HIV-Infected Patients

• Cardiovascular Disease

HIV - Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

• Additional Considerations for HIV-Infected Postmenopausal Women

HIV - Optimizing Adherence to Antiretroviral Therapy

• Attention to Comorbidities
• Comorbidities

HIV - Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care

• Calcium Channel Blockers and Other Cardiac Medications
• Alpha-blockers
• Beta-blockers

Guidelines

• AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
• British HIV Association Guidelines for the Treatment of HIV-1-Positive Adults With Antiretroviral Therapy
• European Guidelines for Treatment of HIV-Infected Adults in Europe—Part III Guidelines for the Prevention and Management of Comorbidities in HIV-Positive Persons
• Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)–Infected Adults Receiving Antiretroviral Therapy